Full List Of Stories
Director dealings: Cohort CEO makes share sale
Cohort revealed on Friday that chief executive Andrew Thomis had disposed of 3,792 ordinary shares in the AIM-listed management consultant.
Broker tips: Shell, Standard Chartered, Team 17, AJ Bell
RBC Capital Markets has raised its forecasts for Shell and kept an 'outperform' rating, saying the business was "firing on most cylinders" in the quarter.
US open: Stocks sharply higher following NFP data
Wall Street stocks were firmly in the green early on Friday as market participants digested some key jobs data.
US pre-open: Futures in the green ahead of April NFP report
Wall Street futures were in the green ahead of the bell on Friday ahead of key jobs data.
Berenberg raises target price on Standard Chartered
Analysts at Berenberg raised their target price on multinational bank Standard Chartered from 1,050. 0p to 1,100. 0p on Friday after the group's Q1 earnings "validated" management's suggestion that the bank had experienced "an encouraging start" to the year.
Credit Agricole Q1 earnings grow, corporate and investment units outperform rivals
French banking group Credit Agricole said on Friday that first-quarter earnings had grown as its corporate and investment banking units outperformed rivals.
Angle strikes supplier deal with AstraZeneca
Liquid biopsy technology firm Angle has struck a supplier deal with pharmaceutical giant AstraZeneca to develop an androgen receptor detection assay to enhance prostate cancer studies.